FlowBank

1065 days ago

Lyft beat estimates--on edge of a cashflow breakeven

''With the world slowly emerging from the covid pandemic, ridesharing services are seeing an impressive return to normalcy as the just released results from Lyft showed. After seeing its revenue crash as much as 61% in the first full post-covid quarter, moments ago Lyft reported that in Q1 2021, earnings were down 36% from a year ago (and up 7% from Q4), the smallest decline in a year, even if total revenues of $609MM (which beat exp of $557.3MM) were still some $350MM shy of the $955MM it made a year ago, thanks to 13.5 million active riders, above the estimated 12.7 million.''

#Technology

1065 days ago

How much time do you spend on mobile+ ? Time is money for tech firms.

In 2021, collective media consumption continues its upward trajectory, and is set to be at the highest it’s ever been. In 2021, overall media consumption among U.S. adults is estimated to be around 666 minutes per day, or 11.1 hours—a 20.2% increase from 2011.

#Technology

1065 days ago

Non profitable tech stocks soared, but lost 30%

Non-profitable tech stocks soared 437% since March 2020, but their gains are fading as the basket lost 30% of its value since the mid-February peak.

#Stocks #Technology
Non profitable tech stocks soared, but lost 30%

1065 days ago

Cable holds 65% market share, but could lose out on 5G deployments

Cable operators face the biggest challenge, a result of dominant market share. The telcos are redoubling their fiber investments, including extending fiber-to-the-home, or FTTH, for wireline services and to support 5G offerings with an increasing focus on fixed wireless services for home broadband. Moreover, the satellite segment is also set for an infusion from Starlink that promises to generate ample buzz, if not a meaningful share shift.

#Technology

1066 days ago

BioNTech stock rallies past $200 a share

The vaccine maker BioNTech which partnered with Pfizer  to develop its Covid-19 vaccine rose 10% in Monday trading, with the stock price going past $200, a new high for the share.  Vaccines are starting to win, and the biotech sector is bouncing back.

#Stocks #Technology
BioNTech stock rallies past $200 a share
bg_newsletter